Egypt’s pharmaceutical manufacturer EVA Group has signed a strategic partnership deal with Eli Lilly and Company, a global healthcare leader.
Under this partnership, EVA Group will import, market, and distribute Eli Lilly’s products in the Egyptian market.
Riad Armanious, EVA Group Managing Director, said, “The partnership between EVA Group and Eli Lilly is a great milestone for both companies as well as the healthcare providers and patients who need Eli Lilly’s innovative therapies.”
He added that this deal comes as a continuation of the multiple successes achieved by EVA in providing the latest medications in Egypt and around 40 countries around the world, including medicines for various chronic diseases.
In regards of distribution, Co-Managing Director of EVA Group, Linda Armanious, said, “With our in-depth knowledge of the local market and commercialization capabilities, we will expand the access of innovative healthcare in Egypt.”
Ahmed Fahmy, General Manager for Eli Lilly North East Africa, said, “Through our partnership with EVA Group, Eli Lilly’s products will continue to be present in Egypt, fulfilling our promise and ensuring that our medicines are accessible to more patients in Egypt.”
